Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) COO Melissa Baird sold 11,750 shares of Hims & Hers Health stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.08, for a total transaction of $141,940.00. Following the completion of the transaction, the chief […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Soleil Boughton sold 2,503 shares of the company’s stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $13.95, for a total transaction of $34,916.85. Following the completion of the sale, the insider now directly owns 164,363 […]
Canaccord Genuity Group assumed coverage on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage issued a buy rating and a $20.00 price objective on the stock. HIMS has been the topic of a number of other research reports. Truist Financial increased […]
Hims & Hers Health (NYSE:HIMS – Get Free Report) issued its earnings results on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.03, Briefing.com reports. The company had revenue of $246.60 million for the quarter, compared to analysts’ expectations of $245.84 million. Hims & […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) CFO Oluyemi Okupe sold 8,509 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $10.03, for a total transaction of $85,345.27. Following the completion of the sale, the chief financial officer now owns […]